Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy

Inclusion Criteria:

   - Healthy non-smoking post menopausal women with absence of menstruation of at least 12
   months

   - Exhibiting VVA symptoms

   - Prolapse staged < II, according to the pelvic organ prolapse quantification
   (ICS-POP-Q) system

   - Have not had procedures in the anatomical area through 6 months prior to treatment

   - Understand and accept the obligation and is logistically able to present for all
   scheduled follow-up visits

Exclusion Criteria:

   - • Acute or recurrent urinary tract infection (UTI), or genital infection (e.g. herpes
   candida).

      - Prolapse staged ≥ II, according to the pelvic organ prolapse quantification
      (ICS-POP-Q) system

      - Any serious disease, or chronic condition, that could interfere with the study
      compliance

      - Previously undergone reconstructive pelvic surgery

      - Have used vaginal creams, moisturizers, lubricants or homeopathic preparations
      for at least 3 months

      - A history of thrombophlebitis

      - A history of acute infections

      - A history of heart failure

      - Received or is anticipated to receive antiplatelets, anticoagulants,
      thrombolytics, vitamin E or anti inflammatories within 2 weeks pre treatment

      - Any medical condition, that, in the investigator's opinion would interfere with
      the patient's participation in the study

      - Taking medications that are photosensitive

      - A history of keloid formation